SEARCH

SEARCH BY CITATION

References

  • Armstrong-James M. and Millar J. (1979) Carbon fibre microelectrodes. J. Neurosci. Methods 1, 279287.
  • Blandini F., Nappi G., Tassorelli C. and Martignoni E. (2000) Functional changes of the basal ganglia circuitry in Parkinson’s disease. Prog. Neurobiol. 62, 6388.
  • Bull D. R., Palij P., Sheehan M. J., Millar J., Stamford J. A., Kruk Z. L. and Humphrey P. P. (1990) Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. J. Neurosci. Methods 32, 3744.
  • Cadogan A. K., Alexander S. P., Boyd E. A. and Kendall D. A. (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69, 11311137.
  • Cheer J. F., Wassum K. M., Sombers L. A., Heien M. L., Ariansen J. L., Aragona B. J., Phillips P. E. and Wightman R. M. (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 27, 791795.
  • Fernandez-Ruiz J. and Gonzales S. (2005) Cannabinoid control of motor function at the basal ganglia. Handb. Exp. Pharmacol., 168, 479507.
  • Freund T. F., Katona I. and Piomelli D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 10171066.
  • Fuxe K., Marcellino D., Rivera A. et al. (2008) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58, 415452.
  • Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., De Costa B. R. and Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563583.
  • Hermann H., Marsicano G. and Lutz B. (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451460.
  • Kathmann M., Bauer U., Schlicker E. and Gothert M. (1999) Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch. Pharmacol. 359, 466470.
  • Kearn C. S., Blake-Palmer K., Daniel E., Mackie K. and Glass M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 16971704.
  • Kruk Z. L. and O’Connor J. J. (1995) Fast electrochemical studies in isolated tissues. Trends Pharmacol. Sci. 16, 145149.
  • Lau T. and Schloss P. (2008) The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. Eur. J. Pharmacol. 578, 137141.
  • Ledent C., Valverde O., Cossu G. et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401404.
  • Limberger N., Trout S. J., Kruk Z. L. and Starke K. (1991) “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623629.
  • Marcellino D., Carriba P., Filip M. et al. (2008) Antagonistic cannabinoid CB(1)/dopamine D(2) receptor interactions in striatal CB(1)/D(2) heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54, 815823.
  • Martin A. B., Fernandez-Espejo E., Ferrer B., Gorriti M. A., Bilbao A., Navarro M., Rodriguez de Fonseca F. and Moratalla R. (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 33, 16671679.
  • Matsuda L. A. (1997) Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11, 143166.
  • Matsuda L. A., Bonner T. I. and Lolait S. J. (1992) Cannabinoid receptors: which cells, where, how, and why? NIDA Res. Monogr. 126, 4856.
  • McDonald R. J. and Hong N. S. (2004) A dissociation of dorso-lateral striatum and amygdala function on the same stimulus-response habit task. Neuroscience 124, 507513.
  • Meschler J. P. and Howlett A. C. (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40, 918926.
  • Millar J. and Barnett T. G. (1988) Basic instrumentation for fast cyclic voltammetry. J. Neurosci. Methods 25, 9195.
  • Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M. and Lewis G. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.
  • Moreno M., Lopez-Moreno J. A., Rodriguez de Fonseca F. and Navarro M. (2005) Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats. Behav. Pharmacol. 16, 441446.
  • O’Neill C. and O’Connor J. J. (2008) An investigation into the influence of NMDA and GABA on the modulation of electrically stimulated dopamine release by adenosine in the rat striatum: studies using fast cyclic voltammetry. Sensors 8, 52295237.
  • O’Neill C., Nolan B. J., Macari A., O’Boyle K. M. and O’Connor J. J. (2007) Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors. Eur. J. Neurosci. 26, 34213428.
  • Pearson Z. S. and Rice M. E. (2004) Cannabinoid receptors modulate dopamine release in guinea pig dorsal and ventral striatum. Neuroscience 953, 4.
  • Pertwee R. G. (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. (Lond) 30 (Suppl. 1), S13S18.
  • Price D. A., Owens W. A., Gould G. G., Frazer A., Roberts J. L., Daws L. C. and Giuffrida A. (2007) CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J. Neurochem. 101, 389396.
  • Rodriguez de Fonseca F., Del Arco I., Martin-Calderon J. L., Gorriti M. A. and Navarro M. (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol. Dis. 5, 483501.
  • Schlicker E. and Kathmann M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565572.
  • Sidlo Z., Reggio P. H. and Rice M. E. (2008) Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels. Neurochem. Int. 52, 8088.
  • Van Der Stelt M. and Di Marzo V. (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol. 480, 133150.
  • Szabo B. and Schlicker E. (2005) Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. 168, 327365.
  • Szabo B., Muller T. and Koch H. (1999) Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J. Neurochem. 73, 10841089.
  • Twitchell W., Brown S. and Mackie K. (1997) Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78, 4350.
  • Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M. and Watanabe M. (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27, 36633676.